The Novel Innovations for Tissue Regeneration in Osteoarthritis will explore ways to help the human body repair its own joints, according to a May 18 news release. Under the program, NITRO will explore technologies in three areas: injectable bone regeneration, injectable cartilage regeneration and replacement joints made from human cells.
The program is the first program under the ARPA-H.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
